Beit Jala Pharmaceutical Company reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was JOD 6.72 million compared to JOD 6.23 million a year ago. Net income was JOD 0.413223 million compared to JOD 0.615225 million a year ago. Basic earnings per share from continuing operations was JOD 0.059 compared to JOD 0.088 a year ago.